IRIS PubliCatt

Gambacorta, Maria Antonietta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.858
EU - Europa 6.522
AS - Asia 2.344
AF - Africa 88
SA - Sud America 33
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 15.888
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.794
DE - Germania 1.942
SE - Svezia 1.451
IT - Italia 1.054
CN - Cina 827
SG - Singapore 826
IE - Irlanda 444
FR - Francia 363
UA - Ucraina 343
ID - Indonesia 269
GB - Regno Unito 237
IN - India 192
FI - Finlandia 149
RU - Federazione Russa 147
PL - Polonia 109
BE - Belgio 93
TR - Turchia 66
CI - Costa d'Avorio 62
CA - Canada 52
CZ - Repubblica Ceca 46
HK - Hong Kong 35
IR - Iran 28
NL - Olanda 27
JP - Giappone 23
AU - Australia 22
CH - Svizzera 17
PE - Perù 17
AT - Austria 16
LT - Lituania 14
IL - Israele 13
RO - Romania 13
BR - Brasile 11
ES - Italia 11
PH - Filippine 11
PK - Pakistan 11
DZ - Algeria 10
A2 - ???statistics.table.value.countryCode.A2??? 7
EU - Europa 7
GR - Grecia 7
MX - Messico 7
NZ - Nuova Zelanda 7
NO - Norvegia 6
RS - Serbia 6
BG - Bulgaria 5
DK - Danimarca 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
BH - Bahrain 4
CL - Cile 4
EG - Egitto 4
MT - Malta 4
SC - Seychelles 4
VN - Vietnam 4
GE - Georgia 3
KR - Corea 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
PA - Panama 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
IQ - Iraq 2
LV - Lettonia 2
PT - Portogallo 2
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MU - Mauritius 1
MW - Malawi 1
OM - Oman 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
ZA - Sudafrica 1
Totale 15.888
Salva come PNG Salva come JPEG
Città #
Chandler 1.788
Singapore 645
Ashburn 532
Dublin 442
New York 284
Ann Arbor 273
Jakarta 257
Jacksonville 249
San Mateo 245
Milan 209
Rome 197
Wilmington 170
Princeton 146
Nanjing 139
Nürnberg 131
Boston 127
Beijing 119
Marseille 117
Moscow 115
Bremen 114
Cattolica 113
Dearborn 109
Woodbridge 102
Fairfield 96
Houston 91
Los Angeles 88
Brussels 87
Munich 86
Warsaw 86
Redwood City 82
Helsinki 69
Lawrence 65
Abidjan 62
Seattle 56
Izmir 52
Nanchang 50
Leawood 47
Boardman 42
Washington 40
Zhengzhou 39
Chicago 37
Shenyang 37
Brno 35
Detroit 32
Augusta 31
Falls Church 30
Norwalk 30
London 29
Pune 28
Hebei 27
Kunming 26
Frankfurt am Main 25
Hong Kong 24
Ottawa 23
Jiaxing 22
Fremont 21
Hangzhou 21
Toronto 21
Cambridge 20
Lancaster 19
Mountain View 19
Phoenixville 19
Paris 18
Lima 17
Shanghai 17
Tianjin 17
University Park 17
Guangzhou 16
Redmond 16
San Diego 16
Andover 15
Changsha 15
Hefei 15
Kraków 15
Vienna 15
Kish 14
Ningbo 13
Jinan 12
Phoenix 12
Karachi 10
Verona 10
Chengdu 9
Naples 9
Atlanta 8
Brescia 8
Florence 8
Lappeenranta 8
Renton 8
Sacramento 8
Simi Valley 8
Amsterdam 7
Berlin 7
Castelnuovo 7
Cedar Knolls 7
San Francisco 7
Santa Clara 7
Wuhan 7
Belgrade 6
Cuauhtémoc 6
Monmouth Junction 6
Totale 8.758
Salva come PNG Salva come JPEG
Nome #
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 310
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 219
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 198
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 177
Multimodality treatment of unresectable stage III non small cell lung cancer: interim analysis of a phase II trial using preoperative gemcitabine with concurrent radiotherapy 167
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 167
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 167
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 164
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 164
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 162
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 162
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 147
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 147
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 141
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 138
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 137
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 136
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 129
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 129
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 128
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 127
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 124
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 124
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 122
Lung recruitment strategies and surfactant in neonatal intensive care unit 121
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 118
Efficacy of a new technique - INtubate-RECruit-SURfactant-Extubate - "IN-REC-SUR-E" - in preterm neonates with respiratory distress syndrome: study protocol for a randomized controlled trial. 116
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 115
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 115
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 115
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 110
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 109
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 108
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 106
Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases 102
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 102
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 100
An umbrella protocol for standardized data collection (SDC) in rectal cancer: a prospective uniform naming and procedure convention to support personalized medicine 99
Virtual simulation:fifteen years later 95
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 94
191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis 93
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 91
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum 90
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 90
Generator breast datamart—the novel breast cancer data discovery system for research and monitoring: Preliminary results and future perspectives 90
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 88
Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: A multicentric prospective study with external validation. 87
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study 87
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma 87
RANDOMIZED, MULTICENTER, PHASE IIB STUDY OF PREOPERATIVE CHEMORADIOTHERAPY IN T3 MID-DISTAL RECTAL CANCER: RALTITREXED + OXALIPLATIN + RADIOTHERAPY VERSUS CISPLATIN + 5-FLUOROURACIL + RADIOTHERAPY. 86
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. 85
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 85
Low-dose radiotherapy and concurrent FOLFIRI-bevacizumab: A Phase II study 84
The potential predictive value of MRI and PET-CT in mucinous and nonmucinous rectal cancer to identify patients at high risk of metastatic disease 84
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach 84
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 84
IGRT in rectal cancer. 82
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 81
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 80
The INTER-ROMA project--a survey among Italian radiation oncologists on their approach to the treatment of bone metastases 79
Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: Analysis on 1798 patients by prediction model 79
Postoperative 5-FU based radiochemotherapy in rectal cancer: retrospective long term results and prognostic factors of a pooled analysis on 1,338 patients 78
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 78
Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: Single-institution experience and systematic review 77
Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas 77
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 76
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 76
Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications 76
The assisi think tank meeting breast large database for standardized data collection in breast cancer—attm.Blade 75
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 74
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 73
Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis 73
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer 72
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 72
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 72
The role of local excision in rectal cancer after complete response to neoadjuvant treatment 72
Could the surgeon trust to radiotherapy help in rectal cancer? 71
INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures 71
The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. 71
Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer 71
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 70
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 69
Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial 69
SPHINCTER PRESERVATION IN FOUR CONSECUTIVE PHASE II STUDIES OF PREOPERATIVE CHEMORADIATION: ANALYSIS OF 247 T3 RECTAL CANCER PATIENTS. 69
Interventional radiotherapy as exclusive treatment for primary nasal vestibule cancer: Single-institution experience 69
MITHRA - Multiparametric MR/CT image adapted brachytherapy (MR/CT-IABT) in anal canal cancer: A feasibility study 68
A radiotherapy staff experience of gratitude during COVID-19 pandemic 68
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 67
Developing and validating ultrasound-based radiomics models for predicting high-risk endometrial cancer 67
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 66
Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience 66
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 66
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer 66
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 66
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 66
EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe 65
A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer 65
Avatar: Analysis for visual acuity prediction after eye interventional radiotherapy 65
Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging. 64
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation 64
Totale 10.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.042 0 0 0 0 112 121 152 55 178 62 265 97
2020/20211.094 85 102 28 109 169 52 111 31 128 68 162 49
2021/20222.024 181 77 35 166 86 72 32 268 133 143 446 385
2022/20234.982 649 651 372 773 278 591 261 395 587 153 194 78
2023/20242.659 108 690 127 186 130 462 164 94 31 97 280 290
2024/20251.424 113 150 422 220 519 0 0 0 0 0 0 0
Totale 16.218